Anticoagulant-Associated Hair Loss

Medication-Induced Alopecia

• The British Journal of Dermatology and the Journal of the American Academy of Dermatology report that retinoids, such as acitretin, can cause hair loss in up to 75% of patients, with higher rates in women at doses exceeding 17.5 mg daily 1, 2
• The pattern of drug-induced hair loss typically presents as a diffuse, non-scarring pattern that is reversible upon drug withdrawal, with telogen effluvium beginning 1-3 months after medication initiation, and resolution within 3-6 months as the body adjusts, with hair growth occurring at approximately 1 cm/month 3, 4

Isotretinoin-Induced Hair Loss

Incidence and Dose Relationship

• The British Journal of Dermatology reports that isotretinoin demonstrates "less hair loss" compared to acitretin, another retinoid that causes hair loss in up to 75% of patients 5

Isotretinoin and Hair Growth Effects

Primary Effect: Hair Loss

• Isotretinoin primarily causes hair loss (telogen effluvium), not hirsutism or hypertrichosis, with the exception of one isolated case report of severe facial hirsutism 6, 7
• Isotretinoin demonstrates "less hair loss" compared to acitretin, which causes alopecia in up to 75% of patients 6, 7

Rare Paradoxical Effect: Hirsutism and Clinical Distinction

• The American Academy of Dermatology recommends that hirsutism, acne, and male-pattern hair loss should prompt endocrine testing for hyperandrogenism 8

Hair-Related Side Effects of Isotretinoin

Incidence and Severity

• Frank alopecia (severe hair loss) occurs in less than 10% of treated patients, according to the British Journal of Dermatology 9
• For patients experiencing significant hair loss during treatment, consider dose reduction rather than complete discontinuation if acne control is adequate, as recommended by the British Journal of Dermatology 9

Isotretinoin-Induced Hair Loss

Incidence and Risk Factors

• The American Academy of Dermatology guidelines list alopecia as a recognized adverse effect of isotretinoin, though frank alopecia occurs in less than 10% of treated patients 10, 11
• Isotretinoin demonstrates "less hair loss" compared to acitretin, another retinoid that causes alopecia in up to 75% of patients 12
• Older age at time of treatment is associated with an increased risk of hair loss 13

Clinical Significance and Management

• The American Academy of Dermatology guidelines emphasize that patients with psychosocial burden or scarring should be considered candidates for isotretinoin, despite the risk of hair loss 13, 14
• Consider dose reduction rather than complete discontinuation if acne control is adequate, as hair loss is typically reversible 10, 11